Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.20    -1.00 (-0.97%)
Bid:
101.60
Ask:
102.20
Spread: 0.60 (0.591%)
Market Cap: £167.55m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

19 Oct 2009 07:00

RNS Number : 9424A
Yule Catto & Co PLC
19 October 2009
 



Yule Catto & Co plc 

Interim Management Statement

Yule Catto & Co plc, the international producer of speciality chemicals, today issues its interim management statement for the period 1 July to 30 September 2009.

The Group delivered a strong financial performance in the third quarter, exceeding the expectations of the Board at the time of its Interim Report.

In Polymer Chemicals, monomer prices increased as expected. Volumes, which were almost 15% down in the first half of the year, were less than 10% down in the quarter compared to quarter three 2008, bettering the anticipated 10-15% decline. This, together with continued good cost control and the weak pound, meant Polymers delivered a strong third quarter.

Pharma Chemicals is seasonally weak in the third quarter due to the summer shutdown period in continental Europe. We continued to see the lower volumes in the business that we experienced through the first half, but the business remains ahead of prior year as at the end of September. 

William Blythe's performance was in line with the first half of the current year, and is well ahead of last year for the nine month period.

The Group announced a number of cost reduction initiatives with its full year 2008 results which have delivered as planned.

Good progress was made on reducing Group net debt, which fell further during the quarter. In September the Group repaid the £33M current installment of its term loans, without recourse to its three year £30M revolving bank loan facility arranged in December 2008, which remained undrawn as at the end of September.

With the strong third quarter, Group profit before tax at the nine months is now well ahead of the same period last year. Raw material price rises are putting pressure on margins, and we are working to recover this through selling prices and this looks likely to persist throughout 2010. Substantial uncertainty about the global economic situation clearly remains. There has been some customer restocking during the first nine months, and whilst Polymer volumes will be ahead for the fourth quarter, we remain cautious about volume development in 2010. For the current year though, following the strong third quarter performance of the Group, the Board now expects full year underlying profit before tax for the group to substantially exceed 2008.

19 October 2009

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Group Finance Director 

 

Hogarth Partnership Limited

Tel: 020 7357 9477

Andrew Jaques

John Olsen

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSILFESIALRLIA
Date   Source Headline
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update
18th Dec 20147:00 amRNSBoard Changes
18th Nov 20147:00 amRNSAppointment of Group Chief Executive
28th Oct 20147:00 amRNSInterim Management Statement
22nd Oct 20143:00 pmRNSAcquisition
17th Oct 20141:03 pmRNSDirector/PDMR Shareholding
16th Oct 20143:56 pmRNSDirector/PDMR Shareholding
15th Oct 201412:35 pmRNSDirector/PDMR Shareholding
14th Oct 20142:40 pmRNSDirector/PDMR Shareholding
13th Oct 20149:35 amRNSDirector Declaration
11th Aug 20147:00 amRNSInterim Results
11th Jul 20147:00 amRNSTrading update
1st Jul 20147:00 amRNSAdrian Whitfield to step down as CEO
23rd Jun 201412:01 pmRNSHolding(s) in Company
30th May 20149:24 amRNSHolding(s) in Company
15th May 20144:26 pmRNSDirector/PDMR Shareholding
8th May 201411:25 amRNSDirector/PDMR Shareholding
7th May 20144:35 pmRNSDirector/PDMR Shareholding
1st May 20142:47 pmRNSResult of AGM
1st May 20147:00 amRNSInterim Management Statement
14th Apr 20149:23 amRNSHolding(s) in Company
9th Apr 20143:08 pmRNSHolding(s) in Company
9th Apr 201411:26 amRNSHolding(s) in Company
31st Mar 20149:40 amRNSAnnual Financial Report
14th Mar 20144:17 pmRNSHolding(s) in Company
14th Mar 201411:48 amRNSHolding(s) in Company
12th Mar 20142:40 pmRNSDirector/PDMR Shareholding
6th Mar 20144:15 pmRNSDirector/PDMR Shareholding
6th Mar 20144:12 pmRNSDirector/PDMR Shareholding
5th Mar 20147:00 amRNSChanges to Board Committees
4th Mar 20142:14 pmRNSHolding(s) in Company
28th Feb 20147:01 amRNSPreliminary Results
13th Feb 20142:57 pmRNSHolding(s) in Company
16th Jan 20148:53 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSDirectorate Change
6th Dec 20139:34 amRNSHolding(s) in Company
22nd Nov 20134:08 pmRNSHolding(s) in Company
20th Nov 201311:45 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSCapital Markets Day
12th Nov 20135:06 pmRNSHolding(s) in Company
8th Nov 20133:03 pmRNSHolding(s) in Company
7th Nov 20137:00 amRNSInterim Management Statement
29th Oct 20131:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.